The about 300 medical technology companies and 230 biotechnology companies, 30 pharmaceuticals manufacturers and more than 130 hospitals of the capital region have made it the premier location for healthcare industries in all of Germany. Approximately 354,000 people work in the Capital region healthcare industry. To name but a few, Bayer AG, Bausch + Lomb, B. Braun Melsungen, Berlin-Chemie, Biotronik, Pfizer and Sanofi all have their registered offices in Berlin.
„In 2008 we very consciously decided in favor of Berlin, because we wanted to be closer to healthcare policy-makers. Moreover, the Berlin-Brandenburg region offers excellent biomedical research - you won't find a similar cluster of research facilities anywhere else in Germany. Having top-ranked research so close at hand is one of the signature features of the region. At the same time, a vibrant, international startup scene is emerging here that we find quite exciting. (...) And of course we also enjoy the city's vitality, international flavor and cultural diversity. Our employees really appreciate that, and we are glad to have found a home here in the heart of the city.“
35 large research institutes and universities focusing on the life sciences can be found here, including centers of excellence and internationally renowned institutions such as Europe's largest university clinic, Charité, the Max Delbrück Center for Molecular Medicine, the Deutsches Herzzentrum Berlin and other institutes of the Fraunhofer Gesellschaft and Max Planck Society, as well as the Helmholtz and Leibniz Associations. Advanced research and medicine found a home here more than 300 years ago with well-known scientists such as Rudolf Virchow, Robert Koch, Ferdinand Sauerbruch and Emil von Behring.
What attracts these companies to Berlin is the exceptional potential for development and cooperation, characterized in particular by direct access to academic and scientific institutions. The long-standing networks and research groups of the region promote the growth and development processes of individual companies.